Next, we studied the effect of eliminating the contribution of cell-free infection in silico (i.e., we fixed β = 0) to elucidate how the total blocking of cell-free infection by IFN-α treatment could affect the time course of infection. The gene discussed is IFNA1; the disease is infection.